{"id":"https://openalex.org/W2531779599","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","title":"Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).","display_name":"Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2531779599","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","mag":"2531779599"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.9061","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000134312","display_name":"\u00d3scar Puig","orcid":"https://orcid.org/0000-0003-0918-2528","observed_orcids":["https://orcid.org/0000-0003-0918-2528"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oscar Puig","raw_affiliation_strings":["Roche Innovation Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Innovation Center, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":["National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan;","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087923582","display_name":"Sai\u2010Hong Ignatius Ou","orcid":"https://orcid.org/0000-0002-1764-4975","observed_orcids":["https://orcid.org/0000-0002-1764-4975"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sai-Hong Ignatius Ou","raw_affiliation_strings":["University of California, Irvine, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, CA;","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080538468","display_name":"Alberto Chiappori","orcid":"https://orcid.org/0000-0003-0810-7104","observed_orcids":["https://orcid.org/0000-0003-0810-7104"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alberto Chiappori","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028800670","display_name":"Bo H. Chao","orcid":"https://orcid.org/0000-0003-2335-5579","observed_orcids":["https://orcid.org/0000-0003-2335-5579"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bo H Chao","raw_affiliation_strings":["Ohio State University, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University, Columbus, OH;","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015680000","display_name":"Chandra Prakash Belani","orcid":"https://orcid.org/0000-0001-5049-5329","observed_orcids":["https://orcid.org/0000-0001-5049-5329"]},"institutions":[{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chandra Prakash Belani","raw_affiliation_strings":["Penn State Hershey Cancer Institute, Hershey, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Cancer Institute, Hershey, PA;","institution_ids":["https://openalex.org/I4405268258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044613951","display_name":"Alexander I. Spira","orcid":"https://orcid.org/0000-0003-1303-0447","observed_orcids":["https://orcid.org/0000-0003-1303-0447"]},"institutions":[{"id":"https://openalex.org/I4210122908","display_name":"Virginia Cancer Specialists","ror":"https://ror.org/03tbabt10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122908"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander I. Spira","raw_affiliation_strings":["Virginia Cancer Specialists Research Institute, and Oncology Research, Fairfax, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Cancer Specialists Research Institute, and Oncology Research, Fairfax, VA;","institution_ids":["https://openalex.org/I4210122908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026639715","display_name":"Alessandra Bearz","orcid":"https://orcid.org/0000-0003-1020-2338","observed_orcids":["https://orcid.org/0000-0003-1020-2338"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandra Bearz","raw_affiliation_strings":["IRCCS Centro Rif Oncologico, Aviano, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Centro Rif Oncologico, Aviano, Italy;","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043441875","display_name":"M. Duruisseaux","orcid":"https://orcid.org/0000-0003-1495-0966","observed_orcids":["https://orcid.org/0000-0003-1495-0966"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michael Duruisseaux","raw_affiliation_strings":["CHU Grenoble, Grenoble, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Grenoble, Grenoble, France;","institution_ids":["https://openalex.org/I2800555055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087892949","display_name":"John D. Allard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Allard","raw_affiliation_strings":["Roche Innovation Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Innovation Center, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013810520","display_name":"Fabian Birzele","orcid":"https://orcid.org/0000-0001-8744-9561","observed_orcids":["https://orcid.org/0000-0001-8744-9561"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fabian Birzele","raw_affiliation_strings":["Roche Innovation Center, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Innovation Center, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090730919","display_name":"Fr\u00e9d\u00e9ric Boisserie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederic Boisserie","raw_affiliation_strings":["Roche Innovation Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Innovation Center, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065805863","display_name":"Ulrika L\u00f6nngren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ulrika Lonngren","raw_affiliation_strings":["Roche Innovation Center, Welwyn Garden City, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Innovation Center, Welwyn Garden City, United Kingdom;","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062173452","display_name":"Walter Bordogna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Walter Bordogna","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111761033","display_name":"Daniel M. Klass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel M. Klass","raw_affiliation_strings":["Roche Molecular Systems, Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Molecular Systems, Pleasanton, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002498799","display_name":"Aaron M. Newman","orcid":"https://orcid.org/0000-0002-1857-8172","observed_orcids":["https://orcid.org/0000-0002-1857-8172"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Newman","raw_affiliation_strings":["Division of Oncology, Stanford University School of Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Stanford University School of Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083698345","display_name":"Ali Hassan Zeaiter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ali Hassan Zeaiter","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080311196","display_name":"Alice Tsang Shaw","orcid":"https://orcid.org/0000-0001-6337-1093","observed_orcids":["https://orcid.org/0000-0001-6337-1093"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Tsang Shaw","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"9061","last_page":"9061"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alectinib","display_name":"alectinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/alk-positive-non-small-cell-lung-cancer","display_name":"ALK-positive non-small cell lung cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/alk-resistance-mutations","display_name":"ALK resistance mutations","score":0.8199999928474426},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.7039999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8579999804496765}],"concepts":[{"id":"https://openalex.org/C2779220645","wikidata":"https://www.wikidata.org/wiki/Q21099132","display_name":"Alectinib","level":5,"score":0.9958813190460205},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.9641660451889038},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.775585412979126},{"id":"https://openalex.org/C2778347629","wikidata":"https://www.wikidata.org/wiki/Q4652380","display_name":"ALK inhibitor","level":5,"score":0.600732684135437},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5732797384262085},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.551213264465332},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5417575836181641},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.48335570096969604},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4324200749397278},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3494724631309509},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12461090087890625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11045220494270325},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07539498805999756},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.0},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.9061","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9061","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2533300620","https://openalex.org/W2164417164","https://openalex.org/W2792034737","https://openalex.org/W2439383252","https://openalex.org/W2267327639","https://openalex.org/W4232445662","https://openalex.org/W2755971997","https://openalex.org/W2809930967","https://openalex.org/W2319183095","https://openalex.org/W2000545640"],"abstract_inverted_index":{"9061":[0],"Background:":[1],"TheALK":[2],"inhibitor":[3],"alectinib":[4,57,96,241,275,285],"is":[5,286],"FDA-approved":[6],"for":[7,106,146,149,154,161,167,218,267],"the":[8,27,54,198],"treatment":[9,311],"of":[10,36,56,169,202],"patients":[11],"(pts)":[12],"with":[13,82,131,229,243,252,312],"ALK+":[14,83],"NSCLC":[15,84],"who":[16,85],"have":[17],"progressed":[18,87],"on,":[19],"or":[20,237,253],"are":[21,182],"intolerant":[22],"to,":[23],"crizotinib,":[24,128],"based":[25],"on":[26,48,58,88,139],"NP28673":[28,74],"(NCT01801111)":[29],"and":[30,75,101,166,177,260,292,306,333],"NP28761":[31,78],"(NCT01871805)":[32],"trials.":[33],"Long-term":[34],"effectiveness":[35],"ALK":[37,43,60,108,189,255,268,291,294],"inhibitors":[38],"can":[39,297],"be":[40,319],"limited":[41],"by":[42],"resistance":[44,208,299,325],"mutations":[45,62,190,206,258,270,303,326],"that":[46,284,296],"occur":[47,309],"treatment.":[49,264],"This":[50],"mutation":[51,109],"analysis":[52],"assessed":[53],"efficacy":[55],"different":[59],"point":[61],"using":[63,111],"pooled":[64],"data":[65,174,282],"from":[66,175,179],"these":[67,244],"two":[68,133],"pivotal":[69],"studies.":[70],"Methods:":[71],"The":[72],"global":[73],"North":[76],"American":[77],"studies":[79],"enrolled":[80],"pts":[81,91,163,170,181,228,251],"had":[86],"crizotinib.":[89,301],"All":[90],"received":[92],"600":[93],"mg":[94],"oral":[95],"twice":[97],"daily.":[98],"Optional":[99],"tissue":[100,121,134,143,151,176],"plasma":[102,178,278,317],"samples":[103,122,135,158],"were":[104,123,159,191,194,210],"collected":[105],"exploratory":[107],"analyses":[110],"next-generation":[112],"sequencing":[113],"methods":[114],"including":[115,304],"CAPP-Seq.":[116],"Results:":[117],"For":[118,141],"most":[119],"pts,":[120],"available":[124,145,153,160],"at":[125,164,171,200],"baseline":[126,165,230],"(after":[127],"before":[129],"alectinib),":[130],"only":[132],"obtained":[136],"after":[137,274],"progression":[138],"alectinib.":[140,313],"NP28673,":[142],"was":[144,152,225,248],"94/138":[147],"pts;":[148],"NP28761,":[150],"35/134":[155],"pts.":[156],"Plasma":[157],"all":[162],"~50%":[168],"progression.":[172],"Preliminary":[173],"51":[180],"reported":[183],"here.":[184],"At":[185],"baseline,":[186],"13":[187],"functional":[188],"identified":[192],"(5":[193],"previously":[195],"unreported":[196],"in":[197,227,250,277,316],"literature);":[199],"end":[201],"treatment,":[203],"3":[204,223],"new":[205],"(known":[207],"mutations)":[209],"seen":[211,226],"(I1171N,":[212],"I1171S,":[213],"G1202R;":[214],"n":[215],"=":[216],"1":[217],"each":[219],"mutation).":[220],"PFS":[221,247],">":[222],"months":[224],"F1174V,":[231],"L1196M,":[232],"S1157F,":[233],"R1231W,":[234],"G1128A,":[235],"G1269A":[236],"C1156F":[238],"mutations,":[239],"suggesting":[240],"activity":[242],"variants.":[245],"Median":[246],"similar":[249],"without":[254],"mutations.":[256],"Resistance":[257,302],"I1171S/N":[259,305],"G1202R":[261,307],"developed":[262],"during":[263,310,327],"Allele":[265],"frequency":[266],"sensitive":[269],"(e.g.":[271],"C1156F)":[272],"decreased":[273],"therapy":[276],"samples.":[279],"Conclusions:":[280],"These":[281],"suggest":[283],"clinically":[287],"active":[288],"against":[289],"native":[290],"several":[293],"variants":[295],"cause":[298],"to":[300,323],"may":[308,318],"Tumor":[314],"DNA":[315],"a":[320],"non-invasive":[321],"way":[322],"monitor":[324],"therapy.":[328],"Clinical":[329],"trial":[330],"information:":[331],"NCT01801111":[332],"NCT01871805.":[334]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-22T17:25:34.749102","created_date":"2025-10-10T00:00:00"}